BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/11/2018 8:28:49 AM | Browse: 1227 | Download: 1188
 |
Received |
|
2018-02-19 23:04 |
|
Peer-Review Started |
|
2018-02-19 23:17 |
|
To Make the First Decision |
|
2018-03-14 00:27 |
|
Return for Revision |
|
2018-03-17 08:01 |
|
Revised |
|
2018-03-19 22:05 |
|
Second Decision |
|
2018-03-22 09:17 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-03-25 16:37 |
|
Articles in Press |
|
2018-03-25 16:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-04-10 06:49 |
|
Publish the Manuscript Online |
|
2018-04-11 08:28 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ivana Mikolasevic, Tajana Filipec Kanizaj, Maja Mijic, Ivan Jakopcic, Sandra Milic, Irena Hrstic, Nikola Sobocan, Davor Stimac and Patrizia Burra |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ivana Mikolasevic, MD, PhD, Associate Professor, Doctor, Department of Internal Medicine, Division of Gastroenterology, Clinical Hospital Centre Rijeka, Rijeka, Croatia, Kresimirova 42, Rijeka 51000, Croatia. ivana.mikolasevic@gmail.com |
| Key Words |
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Chronic liver disease; Liver transplantation; Outcome |
| Core Tip |
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) is a challenging and multisystem disease that has a high socioeconomic impact. NAFLD/NASH is a primary cause of macrovesicular steatosis and has several impacts on liver transplantation (LT), which is transmitted to transplant recipients and organ donors. Current data indicate a new trend in the area of chronic liver disease. Due to the increased incidence of metabolic syndrome (MetS) and its components, NASH cirrhosis and hepatocellular carcinoma caused by NASH will soon become a major indication for LT. |
| Publish Date |
2018-04-11 08:28 |
| Citation |
Mikolasevic I, Filipec-Kanizaj T, Mijic M, Jakopcic I, Milic S, Hrstic I, Sobocan N, Stimac D, Burra P. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? World J Gastroenterol 2018; 24(14): 1491-1506 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i14/1491.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i14.1491 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
